Skin News and Research

RSS

Cooling burns with running water is the best initial treatment, study reveals

New research in the January edition of Annals of Emergency Medicine reveals that cooling with running water is the best initial treatment for a child's burn.

30 Jan 2020

NC State researchers report enhancements to flexible body heat harvester

North Carolina State University engineers have demonstrated a flexible device that harvests the heat energy from the human body to monitor health. The device surpasses all other flexible harvesters that use body heat as the sole energy source.

30 Jan 2020

Researchers use new technique to improve the ability to model lung diseases

Using a combination of pluripotent stem cells (cells that can potentially produce any cell or tissue type) and machine learning (artificial intelligence that allows computers to learn automatically), researchers have improved how they generate lung cells.

30 Jan 2020

Increased brain growth, mutations and autism linked in new study

Salk Institute researchers have now found a pattern of DNA damage that is unique to brain cells derived from individuals with a single form of autism spectrum disorder (ASD) called macrocephalic ASD. The study, published in the journal Cell Stem Cell in January 2020, may offer an explanation about the developmental misstep that caused this disease.

30 Jan 2020

Future of cardiovascular disease management revolves around remote patient monitoring

Cardiovascular disease must be better managed for patient care to improve. The protocols for monitoring patients are rapidly evolving. Historically, patients who fall ill are required to travel in order to visit a general practitioner or hospital. This procedure may soon become a thing of the past.

From IDTechEx Ltd 30 Jan 2020

HA dermal filler treatment can restore youthful facial movement, indicates study

Using 3D digital stereophotogrammetry, the study suggests that hyaluronic acid (HA) dermal filler treatment can restore a more youthful pattern of facial expressiveness.

30 Jan 2020

New strategy using organoids to study childhood brain tumors

A new study reports the creation of in vitro models of brain tumors in children using organoids derived from stem cells, which will help to screen new drugs for efficacy and thus improve the rate of drug development. The study, titled 'Modeling medulloblastoma in vivo and with human cerebellar organoids,' is published in the journal Nature Communications.

29 Jan 2020

Hokkaido University scientists reveal missing link in rare inherited skin disease

Hokkaido University scientists are getting closer to understanding how a rare hereditary disease impairs the skin's barrier function, which determines how well the skin is protected.

29 Jan 2020

New blood sugar tool could one day replace uncomfortable finger-prick test

Researchers have developed a new way to monitor blood sugar levels that could replace the needle-prick method that people with diabetes currently use.

29 Jan 2020

Researchers develop new strategy to study childhood brain tumors

Researchers are at work to find effective treatments to help young patients with brain tumors. Hundreds of brain organoids have been developed in the laboratories of the University of Trento to understand the genetic mechanisms responsible for these hard to treat diseases.

29 Jan 2020

Bavarian research network aims to develop new approaches against multi-resistant pathogens

Developing fundamental new approaches against multi-resistant pathogens is the aim of the new Bavarian research network called New Strategies Against Multi-Resistant Pathogens by Means of Digital Networking - bayresq.net.

29 Jan 2020

FDA issues stern warning to Purell hand sanitizer maker

The U.S. Food and Drug Administrator has issued a strict warning to Purell-maker GOJO Industries, which claims it hand sanitizers can kill pathogens that cause illness in as little as 15 seconds.

29 Jan 2020

What parents need to know about the HPV vaccine

The vaccine that prevents infection from human papillomavirus (HPV) is nothing short of a medical marvel.

28 Jan 2020

Researchers discover how CDK8 oncogene gets activated in healthy humans

Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be identified. Such genes are called oncogenes. A good example of an oncogene is CDK8: Cyclin-dependent kinase 8.

28 Jan 2020

Non-invasive electrostimulation of the vagus nerve improves memory in mice

Researchers at UPF are testing a new non-invasive method of stimulating the vagus nerve in mice that improves their memory.

28 Jan 2020

Researchers succeed in creating complex pattern of hives

Hives afflict 1 in 5 people, but the exact mechanisms behind the itchy red rashes are not well known. The research team studied the patterns of hives in patients and reproduced the hive patterns using a mathematical model called a reaction-diffusion model, a common prototype for understanding how patterns develop. The researchers' model is a single equation type which had never before been used to generate complex patterns.

28 Jan 2020

Study suggests prenatal origin for ‘young’ Parkinson’s disease

A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson’s disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.

27 Jan 2020

Discovery could unlock new ways to treat a rare blood disease

A cancer researcher at the University of Alberta has made a discovery that could unlock new ways to treat a rare blood disease.

27 Jan 2020

Parkinson's disease may affect brain cells before birth

People who develop Parkinson's disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new Cedars-Sinai research. The research points to a drug that potentially might help correct these disease processes.

27 Jan 2020

Clinical trial to test safety, effectiveness of mAb against malaria in healthy volunteers

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.

27 Jan 2020